Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) pandemic demands reliable prognostic models for estimating the risk of long COVID. We developed and validated a prediction model to estimate the probability of known common long COVID symptoms at least 60 days after acute COVID-19.

Methods

The prognostic model was built based on data from a multicentre prospective Swiss cohort study. Included were adult patients diagnosed with COVID-19 between February and December 2020 and treated as outpatients, at ward or intensive/intermediate care unit. Perceived long-term health impairments, including reduced exercise tolerance/reduced resilience, shortness of breath and/or tiredness (REST), were assessed after a follow-up time between 60 and 425 days. The data set was split into a der

SUBMITTER: Deforth M 

PROVIDER: S-EPMC9668400 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature